<DOC>
	<DOCNO>NCT01440049</DOCNO>
	<brief_summary>On population patient follow office-based cardiologist treat eplerenone , objectives survey : - To describe characteristic population treat . - To describe method use eplerenone ( posology , duration treatment , medicinal combination ) . - To describe follow-up method treatment . - To describe possible interruption treatment</brief_summary>
	<brief_title>Patient 's Management Receiving Eplerenone Therapy</brief_title>
	<detailed_description>A sample size region N = 400 patient allow accuracy estimation , size , half-width would equal 5 % frequency 50 % correspond confidence interval maximum width . In view type survey need 12 month monitor context standard practice , may anticipate drop-off rate 20 % . A sample size N = 500 patient therefore chosen .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Mineralocorticoid Receptor Antagonists</mesh_term>
	<criteria>The following patient may select participate survey : Those undergoing treatment eplerenone accordance MA , know start date . Those likely follow physician minimal period twelve month . Severe Kidney Disease Hyperkamiemia 5.5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>patient MI- top treatment add Eplerenone - ass LVEF BP</keyword>
</DOC>